<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="22349">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02815891</url>
  </required_header>
  <id_info>
    <org_study_id>TARGET-NASH</org_study_id>
    <nct_id>NCT02815891</nct_id>
  </id_info>
  <brief_title>A 5-year Longitudinal Observational Study of Patients With Nonalcoholic Fatty Liver (NAFL) or Nonalcoholic Steatohepatitis (NASH)</brief_title>
  <official_title>A 5-year Longitudinal Observational Study of Patients With Nonalcoholic Fatty Liver (NAFL) or Nonalcoholic Steatohepatitis (NASH)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Target PharmaSolutions, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Target PharmaSolutions, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      TARGET-NASH is a longitudinal observational cohort study of patients being managed for NAFL
      or NASH in usual clinical practice. TARGET-NASH will create a research registry of patients
      with NAFL or NASH within academic and community real-world practices in order to assess the
      safety and effectiveness of current and future therapies.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Anticipated">July 2021</completion_date>
  <primary_completion_date type="Anticipated">July 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>Establish an understanding of the current natural history of NASH at academic and community medical centers</measure>
    <time_frame>up to 5 years</time_frame>
    <description>A detailed analysis of demographics, concurrent medications, metabolic and cardiovascular co-morbidities, staging of liver disease, and outcomes for patients with NASH managed in diverse clinical settings will serve as an important comparator for subsequent interventions that alter the treatment paradigm for this disease.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluate NASH treatment regimens being used in clinical practice</measure>
    <time_frame>up to 5 years</time_frame>
    <description>Currently, there are no FDA approved therapies for NASH, however clinicians may use a variety of interventions including diet and exercise programs, vitamin E, bariatric surgery or other unapproved uses of some cholesterol, lipid lowering, anti-diabetic and anti-inflammatory medications as well as alternative medications. TARGET-NASH will monitor the safety and effectiveness of the various treatment choices in enrolled patients.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Examine populations underrepresented in phase II-III clinical trials</measure>
    <time_frame>up to 5 years</time_frame>
    <description>Patients with cirrhosis, age &gt; 70, patients who consume moderate amounts of alcohol and patients with multiple comorbidities such as severe depression, chronic fatigue, fibromyalgia, type 2 diabetes, inflammatory bowel disease, or cardiovascular disease.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluate optimal duration and combination of NASH therapies to achieve clinical response and clinical remission</measure>
    <time_frame>up to 5 years</time_frame>
    <description>In addition to diet and exercise, type, dose and duration of therapy of each NASH treatment (both current unapproved therapies and future FDA approved drugs) will be closely followed, with a goal to monitor treatment paradigms and various combination regimens for clinical response and clinical remission.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Examine liver histology</measure>
    <time_frame>up to 5 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Estimate adverse event frequency and severity and describe management practices</measure>
    <time_frame>up to 5 years</time_frame>
    <description>NASH can often be an asymptomatic disease in the setting of other disease-related comorbidities such as diabetes and cardiovascular disease. Once NASH progresses to cirrhosis, these patients can suffer the attendant complications of decompensated liver disease including debilitating fatigue, muscle wasting, ascites, bleeding, encephalopathy, hepatocellular carcinoma, and death. NASH therapies may increase the frequency and severity of certain adverse events, such as edema (pioglitazone), some cancers (vitamin E), and new agents or combinations of agents may have their own unique adverse event profiles and varying needs for management plans (e.g., pruritus and dyslipidemia).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluate the impact of NASH therapies on medical co-morbidities</measure>
    <time_frame>up to 5 years</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">15000</enrollment>
  <condition>Nonalcoholic Fatty Liver</condition>
  <condition>Nonalcoholic Steatohepatitis</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Patients enrolled in TARGET-NASH will be invited to participate in the Biorepository
      Specimen Bank (BSB). Blood samples for biomarker and DNA assays will be collected on a
      voluntary basis and participation in this project will not affect participation in the main
      study. These samples will be shipped to a central repository for storage to use in future
      studies. Samples stored at the biorepository will be identified only with the patient's
      unique study ID number and the date that the sample was obtained. This link between the
      patient's study ID number and their name will be available only at the site where the
      samples were obtained.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Adults and children with NAFL or NASH who are being seen specifically to address this
        disease process
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        1. Adults and children (age 6 or older) being managed or treated for NAFL or NASH

        Exclusion Criteria:

          1. Inability to provide written informed assent/consent

          2. Simultaneous enrollment in another registry, study, or clinical trial where NASH
             treatment outcomes are reported, except where approved or conducted as an adjunct
             project of TARGET-NASH
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Laura Malahias</last_name>
    <email>lmalahias@targetpharmasolutions.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Banner University Medical Center - Phoenix Transplant Center and Advanced Liver Clinic</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85006</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Silicon Valley Research Institute</name>
      <address>
        <city>San Jose</city>
        <state>California</state>
        <zip>95128</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angelica Le</last_name>
      <phone>408-347-9001</phone>
      <email>angelicale@sjgi.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Connecticut Gastroenterology</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <zip>06105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raffi Karagozian, MD</last_name>
      <phone>860-522-1171</phone>
      <email>rkaragozian@sfhcp.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>GastroFlorida</name>
      <address>
        <city>Clearwater</city>
        <state>Florida</state>
        <zip>33762</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shannon Brewington, CRC</last_name>
      <phone>727-336-7682</phone>
      <email>sbrewington@gastrofl.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Florida Hepatology Research at CTRB</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610-0272</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cindy Thyberg</last_name>
      <phone>352-273-7279</phone>
      <email>cynthia.thyberg@medicine.ufl.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valerie Myrick</last_name>
      <phone>352-294-5723</phone>
      <email>valerie.myrick@medicine.ufl.edu</email>
    </contact>
    <investigator>
      <last_name>Kenneth Cusi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UF Health Gastroenterology</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32207</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelly Jackman, PhD</last_name>
      <phone>904-633-0070</phone>
      <email>kelly.jackman@jax.ufl.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33009</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marianela Carvajal</last_name>
      <email>mxc1535@miami.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>SCFLD/University of Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claudia Cottone</last_name>
      <phone>305-243-1104</phone>
      <email>cxc1335@med.miami.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Advanced Gastroenterology Associates, LLC</name>
      <address>
        <city>Palm Harbor</city>
        <state>Florida</state>
        <zip>34041</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joanne Root, CCRC</last_name>
      <phone>727-216-0768</phone>
      <email>research@advancedgastro.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Atlanta Gastroenterology Associates</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30308</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne Taylor</last_name>
      <phone>404-881-1094</phone>
      <phone_ext>1210</phone_ext>
      <email>anne.taylor@atlantagastro.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Children's Healthcare of Atlanta</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebecca Cleeton</last_name>
      <phone>404-727-5383</phone>
      <email>rcleeto@emory.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Louisville</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nancy Alsip</last_name>
      <phone>502-852-2905</phone>
      <email>nancy.alsip@louisville.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Houma Digestive Health Specialists</name>
      <address>
        <city>Houma</city>
        <state>Louisiana</state>
        <zip>70360</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cindy Smith</last_name>
      <phone>954-940-8044</phone>
      <email>csmith@houmadigestivehealth.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Louisiana Research Center, LLC</name>
      <address>
        <city>Shreveport</city>
        <state>Louisiana</state>
        <zip>71105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Veronica Greer</last_name>
      <phone>318-213-3453</phone>
      <email>vgreer@gis.md</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mercy Medical Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Veronica Kflu</last_name>
      <phone>410-576-5485</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Wu</last_name>
      <phone>734-647-0236</phone>
      <email>elizwu@med.umich.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Nebraska Medical Center</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amanda Fletcher</last_name>
      <phone>402-552-6120</phone>
      <email>amanda.fletcher@unmc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Children's Hospital at Montefiore, Division of Pediatric GI</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bryan Rudolph, MD</last_name>
      <phone>718-741-2332</phone>
      <email>brudolph@montefiore.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sandra Atlas Bass Center for Liver Diseases</name>
      <address>
        <city>Manhasset</city>
        <state>New York</state>
        <zip>11030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Radica Palmer, NP</last_name>
      <phone>516-562-2082</phone>
      <email>rpalmer@northwell.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Asheville Gastroenterology Associates, PA</name>
      <address>
        <city>Asheville</city>
        <state>North Carolina</state>
        <zip>28801</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>University of North Carolina at Chapel Hill</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Renee T. Blanchard, CCRC</last_name>
      <phone>919-843-5936</phone>
      <email>renee_blanchard@med.unc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Center for Liver Disease and Transplant at CMC</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gale Groseclose</last_name>
      <phone>704-355-4875</phone>
      <email>gale.groseclose@carolinashealthcare.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Digestive Health Specialists, PA</name>
      <address>
        <city>Winston Salem</city>
        <state>North Carolina</state>
        <zip>27103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephanie Riggs</last_name>
      <phone>336-768-6211</phone>
      <email>stephanier@digestivehealth.ws</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>OUHSC/Department of Pediatric GI and Hepatology</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathy Redmond</last_name>
      <phone>405-271-6306</phone>
      <email>Kathy-redmond@ouhsc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ruona Ughwanogho</last_name>
      <phone>215-349-8507</phone>
      <email>Ogheneruona.Ughwanogho@uphs.upenn.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Frank Beylotte, MS</last_name>
      <phone>843-876-4273</phone>
      <email>beylott@musc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gastroenterology Associates</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29615</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Research Specialists of Texas</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wilma Regalado</last_name>
      <phone>713-634-5110</phone>
      <email>wregalado@texasliver.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pinnacle Clinical Research</name>
      <address>
        <city>Live Oak</city>
        <state>Texas</state>
        <zip>78233</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Bon Secours Liver Institute of Virginia</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joyce Soublet, LPN</last_name>
      <phone>757-947-3190</phone>
      <email>joyce_soublet@bshsi.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Washington</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Nguyen</last_name>
      <phone>206-744-3402</phone>
      <email>phnmedic@uw.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 27, 2017</lastchanged_date>
  <firstreceived_date>June 23, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Fatty Liver</mesh_term>
    <mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
